A high PDL-1 expression by cancer cells is commonly seen in advanced tumors, and it binds to PD-1 in infiltrated immune cells, mainly to suppress the mTOR pathway in macrophages and to induce exhaustion in cytotoxic T lymphocytes, which eludes the anti-tumor action by immune cells (70). Here, CD274 is linked to cancer.